Antibiotic Treatment of Anaerobic Infections: Uncharted Land in Iran
Abstract
No Abstract
1. Goldstein EJ, Citron DM (2011). Resistance trends in antimicrobial susceptibility of anaerobic bacteria, part I. Clin Microbiol Newsl, 33(1):1-8.
2. Ghotaslou R, Baghi HB, Alizadeh N, Yekani M, Arbabi S, Memar MY (2018). Mechanisms of Bacteroides fragilis resistance to metronidazole. Infect Genet Evol,64:156-163.
3. Ghotaslou R, Yekani M, Memar MY (2018). The role of efflux pumps in Bacteroides fragilis resistance to antibiotics. Microbiol Res, 210:1-5.
4. Schuetz AN (2014). Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis, 59(5):698-705.
5. Boyanova L, Kolarov R, Mitov I (2015). Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe, 31:4-10.
2. Ghotaslou R, Baghi HB, Alizadeh N, Yekani M, Arbabi S, Memar MY (2018). Mechanisms of Bacteroides fragilis resistance to metronidazole. Infect Genet Evol,64:156-163.
3. Ghotaslou R, Yekani M, Memar MY (2018). The role of efflux pumps in Bacteroides fragilis resistance to antibiotics. Microbiol Res, 210:1-5.
4. Schuetz AN (2014). Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis, 59(5):698-705.
5. Boyanova L, Kolarov R, Mitov I (2015). Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe, 31:4-10.
Files | ||
Issue | Vol 48 No 11 (2019) | |
Section | Letter to the Editor | |
DOI | https://doi.org/10.18502/ijph.v48i11.3537 | |
Keywords | ||
No Keywords |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
MEMAR MY, YEKANI M, AGHAZADEH M, BANNAZADEH BAGHI H. Antibiotic Treatment of Anaerobic Infections: Uncharted Land in Iran. Iran J Public Health. 2019;48(11):2103-2104.